We are live on ! Find out more
DC

Davenport & Co Portfolio holdings

AUM $20.4B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+18.11%
3 Year Est. Return
+63.26%
5 Year Est. Return
+74.4%
10 Year Est. Return
+287.26%
AUM
$14.6B
AUM Growth
-$589M
Cap. Flow
+$114M
Cap. Flow %
0.78%
Top 10 Hldgs %
20.11%
Holding
1,143
New
67
Increased
509
Reduced
402
Closed
83

Top Buys

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$80.7M
2
VZ icon
Verizon
VZ
+$60.3M
3
BAC icon
Bank of America
BAC
+$57.8M
4
SYY icon
Sysco
SYY
+$56.8M
5
C icon
Citigroup
C
+$52.7M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$106M
2
BP icon
BP
BP
+$101M
3
TFC icon
Truist Financial
TFC
+$83.3M
4
MELI icon
Mercado Libre
MELI
+$70.5M
5
AMD icon
Advanced Micro Devices
AMD
+$50.5M

Sector Composition

Rank Sector Weight
1 Financials 17.23%
2 Technology 12.41%
3 Consumer Discretionary 10.69%
4 Healthcare 9.67%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XXII
1051
22nd Century Group
XXII
$1.38M
– –
0
– –
NRXP icon
1052
NRX Pharmaceuticals
NRXP
$135M
$25K ﹤0.01%
1,000
– –
LOTZ
1053
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$24K ﹤0.01%
17,723
+1,864
+12% +$3.52K
RCAT icon
1054
Red Cat Holdings
RCAT
$1.15B
$20K ﹤0.01%
10,000
– –
QTNT
1055
DELISTED
Quotient Limited Ordinary Shares
QTNT
$20K ﹤0.01%
416
– –
CELG.RT
1056
Bristol-Myers Squibb Rights
CELG.RT
$191M
$14K ﹤0.01%
93,770
-967
-1% -$158
CYCN icon
1057
Cyclerion Therapeutics
CYCN
$14.9M
$14K ﹤0.01%
650
+10
+2% +$241
PLX icon
1058
Protalix BioTherapeutics
PLX
$191M
$13K ﹤0.01%
12,000
– –
EVFM
1059
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$13K ﹤0.01%
2,633
-1,767
-40% -$11.1K
CONXW
1060
DELISTED
CONX Corp. Warrant
CONXW
$6K ﹤0.01%
14,250
+297
+2% +$157
AA icon
1061
Alcoa
AA
$11.9B
– –
-4,490
Closed -$268K
ALNY icon
1062
Alnylam Pharmaceuticals
ALNY
$27.5B
– –
-3,705
Closed -$628K
ARKF icon
1063
ARK Blockchain & Fintech Innovation ETF
ARKF
$710M
– –
-10,914
Closed -$446K
BE icon
1064
Bloom Energy
BE
$60.6B
– –
-9,300
Closed -$204K
BIO icon
1065
Bio-Rad Laboratories Class A
BIO
$8.71B
– –
-288
Closed -$218K
BLKB icon
1066
Blackbaud
BLKB
$1.94B
– –
-3,241
Closed -$256K
BMO icon
1067
Bank of Montreal
BMO
$126B
– –
-1,913
Closed -$206K
BPT
1068
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
– –
-20,000
Closed -$79K
BZH icon
1069
Beazer Homes USA
BZH
$877M
– –
-9,700
Closed -$225K
CABO icon
1070
Cable One
CABO
$227M
– –
-121
Closed -$213K
CASH icon
1071
Pathward Financial
CASH
$1.86B
– –
-6,113
Closed -$365K
CLF icon
1072
CALL
Cleveland-Cliffs
CLF
$6.57B
– –
-10,000
Closed -$218K
CMCSA icon
1073
CALL
Comcast
CMCSA
$85B
– –
-435,400
Closed -$21.9M
CNC icon
1074
Centene
CNC
$30.7B
– –
-5,820
Closed -$480K
DNL icon
1075
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$481M
– –
-4,845
Closed -$211K
41 42
43
44 45

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Davenport & Co's Q1 2022 Portfolio in Review

As of Q1 2022, Davenport & Co held 1,143 positions worth $14.6B, down 3.9% from $15.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Davenport & Co's Q1 2022 filing shows 67 new, 509 increased, 402 reduced and 83 closed positions. Its largest new stake was Caesars Entertainment: 1,004,542 shares worth $77.8M. The largest sale was Microsoft, an estimated $106M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Davenport & Co's largest Q1 2022 buy was Caesars Entertainment: 1,004,542 shares worth $77.8M.
  • Davenport & Co added most to Verizon in Q1 2022, an estimated $60.3M increase.
  • Davenport & Co's biggest Q1 2022 reduction was Microsoft, cutting an estimated $106M.
  • Davenport & Co fully exited Royal Dutch Shell PLC ADS Class B in Q1 2022, selling an estimated $10.2M.
  • Davenport & Co's ten largest holdings make up 20% of its $14.6B portfolio in Q1 2022.
  • Davenport & Co opened 67 new positions and closed 83 in Q1 2022.
  • Davenport & Co's portfolio value fell 3.9% quarter-over-quarter to $14.6B.

Based on Davenport & Co's 13F filing for Q1 2022, filed 2 May 2022.